Dun & Bradstreet (DNB) Tops Q3 EPS by 2c

Dun & Bradstreet (NYSE: DNB) reported Q3 EPS of $0.24, $0.02 better than the analyst estimate of $0.22. Revenue for the quarter came in at $442.1 million versus the consensus estimate of $443.55 million.

GUIDANCE:

Dun & Bradstreet sees FY2020 EPS of $0.89-$0.93, versus the consensus of $0.92. Dun & Bradstreet sees FY2020 revenue of $1.729-1.759 billion, versus the consensus of $1.74 billion.

For earnings history and earnings-related data on Dun & Bradstreet (DNB) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
• Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c